论文部分内容阅读
目的探讨血浆D-二聚体、免疫球蛋白(Ig)检测在支原体肺炎治疗中的临床意义。方法 88例支原体肺炎患儿作为观察组,同期32例体检健康儿童作为对照组,检测并对比两组的血浆D-二聚体和Ig A、Ig M、Ig G水平。结果观察组血浆D-二聚体表达水平(1.08±0.36)mg/L、Ig A(1.15±0.36)g/L、Ig M(1.64±0.55)g/L高于对照组的(0.28±0.02)mg/L、(0.67±0.21)g/L、(1.12±0.31)g/L,差异有统计学意义(P<0.05)。结论血浆D-二聚体和免疫球蛋白水平变化能反映支原体肺炎的病情发展,有助于疾病的临床治疗。
Objective To investigate the clinical significance of detecting plasma D-dimer and immunoglobulin (Ig) in mycoplasma pneumonia. Methods 88 children with mycoplasmal pneumonia were selected as the observation group and 32 healthy children as the control group during the same period. Plasma D-dimer and Ig A, Ig M and Ig G levels were measured and compared between the two groups. Results The expression of D-dimer in the observation group was significantly higher than that in the control group (1.08 ± 0.36 mg / L, Ig A (1.15 ± 0.36) g / L, Ig M ) (0.67 ± 0.21) g / L and (1.12 ± 0.31) g / L, respectively. The difference was statistically significant (P <0.05). Conclusion The changes of plasma D-dimer and immunoglobulin levels can reflect the progression of mycoplasma pneumonia and contribute to the clinical treatment of the disease.